Kewalramani Reshma bought VRTX
August 6, 2025 · Form 4 insider transaction
Kewalramani Reshma bought 4,290 shares of Vertex Pharmaceuticals Incorporated at $389.08 per share, a transaction worth $1.67M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
4,290
Price
$389.08
Total value
$1.67M
InsiderKewalramani Reshma
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateAugust 6, 2025
Filing dateAugust 7, 2025
Shares owned after110,258
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Open market purchases reported on this line occurred at a weighted average price of $389.08 (range $388.71 to $389.43).; Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.